IZB Hotspot for Life Sciences

A leading global technology location

The Innovation and Start-up Center Biotechnology (IZB) with sites in Planegg-Martinsried and Freising-Weihenstephan near Munich, is one of the leading biotechnology centers in Europe. The company Fördergesellschaft IZB mbH, founded in 1995, operates IZB. IZB hosts over 40 biotech companies with more than 700 employees across a 26,000 m² area. At the main site in Planegg-Martinsried, spanning 23,000 m², resident start-ups primarily focus on medical biotechnology. IZB in Freising provides ideal conditions for founders in the life sciences sector.

“At IZB, we connect with a unique network of pharmaceutical companies, research institutions, and investors – an ideal ecosystem to drive our biotechnology forward.”
Dr. Luitpold Fried, Managing Director
“The IZB provides our team the perfect environment to kick-start our projects and operations and we are grateful to be part of this community.”
Dr. Adrian Schomburg, CEO & Founder Eisbach Bio GmbH
“The IZB is a lighthouse for innovation. ... The provided space is essential for successfully implementing our pioneering ideas and leaving a lasting impact. ...”
Dr. Patrick Großmann und Dr. Kilian Vogele, Invitris, managing directors
“Since the time we moved to the IZB, our headcount grew steadily from 6 to 60 employees. The IZB supported us continuously and we look forward to being part of the IZB in future.”
Michael Scholl, CEO Leukocare
“As part of the IZB family we have access to a great location and an excellent start-up network.”
Dr. Garwin Pichler, CEO, Dr. Nils Kulak, CEO, PreOmics GmbH
“We are pleased to be part of the IZB family, a leading innovation center in Europe and are looking forward to building a strong research team with local talent and connecting our global team to the renowned scientific community of Munich.”
Dr. Karin Wisskirchen, Managing Director & Head of Research, Dr. Susanne Wilde, Head of Preclinical Research und Dr. Gregory Fanning, Acting-CEO SCG Cell Therapy GmbH
“The IZB provides our team with a valuable infrastructure and network that is conducive to our goal of opening new avenues for the treatment of solid tumors and bringing safe and effective ADCs to patients.”
Dr. Dominik Schumacher, Dr. Jonas Helma-Smets, Tubulis

Proximity to top research

An important criterion for the success of the IZBs is the proximity to the universities and research institutions. The Martinsried science campus is now one of the largest centers in Europe, where basic scientific research, teaching, clinical research and technology innovation are brought together on one campus. There are two Max Planck Institutes, ten departments of the Ludwig Maximilian University, the Großhadern Clinic and the Helmholtz Center on the Martinsried Campus.

The Campus Martinsried

Learn more about the unique location of the IZB

One of the leading technology locations in the world

“Biotechnology is one of the key technologies of the 21st century. 60 percent of the new generation of medicines come from the field of biotechnology. Two-thirds of the biotech companies in Germany are located in Bavaria. This sector dominated by innovation has created many new jobs. The goal of the Bavarian State Government is to maintain and also continue to expand this economic factor. This is why the Federal State of Bavaria offers excellent conditions for the development of new drugs, therapies and services at the Innovation and Start-up Center Biotechnology (IZB), located in Martinsried and Weihenstephan near Munich.”

Yours Hubert Aiwanger Bavarian Minister of State for Economics, Regional Development and Energy Deputy Prime Minister of Bavaria